Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage
Woong‐Ki Kim(Beth Israel Deaconess Medical Center), Kenneth C. Williams(Boston College), Jeffrey D. Lifson(Science Applications International Corporation (United States)), Hien Do, Elkan F. Halpern(Harvard University), Michael S. McGrath(University of California, San Francisco), Tricia H. Burdo(Temple University), Yue Sun(Nanyang Technological University), Michael Piatak, Patrick Autissier(Beth Israel Deaconess Medical Center)
Cited by 96
Related Papers
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
|Blood|2004|787
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
|New England Journal of Medicine|2013|581
Arterial Inflammation in Patients With HIV
|JAMA|2012|460
Soluble CD163, a Novel Marker of Activated Macrophages, Is Elevated and Associated With Noncalcified Coronary Plaque in HIV-Infected Patients
|The Journal of Infectious Diseases|2011|419